Sagittarius Life Science (3205) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 佰研

Sagittarius Life Science (3205) reported revenue of NT$37.8 million for Oct 2026, +125.2% year on year and +5.8% from the previous month. Revenue for Jan–Oct 2026 was NT$475.5 million (+47.1% year on year).

In Oct 2026, it ranked No. 110 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$35.2 million24/10Nov 2024 NT$32.4 millionDec 2024 NT$50.3 millionJan 2025 NT$35 millionFeb 2025 NT$30.8 million25/02Mar 2025 NT$35.1 millionApr 2025 NT$36 millionMay 2025 NT$37.9 millionJun 2025 NT$38.9 million25/06Jul 2025 NT$36.6 millionAug 2025 NT$35.4 millionSep 2025 NT$20.9 millionOct 2025 NT$16.8 million25/10Nov 2025 NT$5.3 millionDec 2025 NT$17.4 millionJan 2026 NT$46.9 millionFeb 2026 NT$39.1 million26/02Mar 2026 NT$61.1 millionApr 2026 NT$60.4 millionMay 2026 NT$86.9 millionJun 2026 NT$40.8 million26/06Jul 2026 NT$31.4 millionAug 2026 NT$35.2 millionSep 2026 NT$35.8 millionOct 2026 NT$37.8 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$37.8 million+125.2%+5.8%
Sep 2026NT$35.8 million+71.1%+1.5%
Aug 2026NT$35.2 million-0.4%+12.1%
Jul 2026NT$31.4 million-14.2%-23.0%
Jun 2026NT$40.8 million+5.0%-53.1%
May 2026NT$86.9 million+129.6%+43.9%
Apr 2026NT$60.4 million+67.9%-1.2%
Mar 2026NT$61.1 million+73.9%+56.5%
Feb 2026NT$39.1 million+26.9%-16.8%
Jan 2026NT$46.9 million+34.0%+169.2%
Dec 2025NT$17.4 million-65.3%+226.7%
Nov 2025NT$5.3 million-83.5%-68.2%
Oct 2025NT$16.8 million-52.3%-19.6%
Sep 2025NT$20.9 million-46.1%-40.9%
Aug 2025NT$35.4 million-9.7%-3.4%
Jul 2025NT$36.6 million+0.2%-5.8%
Jun 2025NT$38.9 million+2.5%+2.6%
May 2025NT$37.9 million-4.7%+5.3%
Apr 2025NT$36 million-7.5%+2.3%
Mar 2025NT$35.1 million-2.1%+14.2%
Feb 2025NT$30.8 million-8.1%-12.2%
Jan 2025NT$35 million-29.1%-30.4%
Dec 2024NT$50.3 million+39.5%+55.2%
Nov 2024NT$32.4 million-7.8%-7.9%
Oct 2024NT$35.2 million+2.7%-9.1%

Jan–Oct 2026 cumulative: NT$475.5 million (+47.1% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Sagittarius Life Science vs PEC / Sagittarius Life Science vs Lotus Pharm / Sagittarius Life Science vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

Company remark (original Chinese)

本月營收成長,主係客戶需求增加所致。

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16